title: NESH protein expression switches to the adverse effect of imatinib mesylate.
authors.forename: Satoru
authors.initials: S
authors.lastname: Matsuda
authors.forename: Yasukatu
authors.initials: Y
authors.lastname: Ichigotani
authors.forename: Naoko
authors.initials: N
authors.lastname: Okumura
authors.forename: Hitomi
authors.initials: H
authors.lastname: Yoshida
authors.forename: Yuka
authors.initials: Y
authors.lastname: Kajiya
authors.forename: Yasuko
authors.initials: Y
authors.lastname: Kitagishi
authors.forename: Naoki
authors.initials: N
authors.lastname: Shirafuji
mesh_terms: D048868:Adaptor Proteins, Signal Transducing / Q000235:genetics / Q000502:physiology*; D001549:Benzamides; D015870:Gene Expression; D006801:Humans; D000068877:Imatinib Mesylate; D008175:Lung Neoplasms / Q000188:drug therapy / Q000473:pathology; D009362:Neoplasm Metastasis; D010879:Piperazines / Q000009:adverse effects* / Q000494:pharmacology; D011743:Pyrimidines / Q000009:adverse effects* / Q000494:pharmacology
chemical_list: C541989:ABI3 protein, human; D048868:Adaptor Proteins, Signal Transducing; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate